GSK to buy US biotech firm IDRx for up to $1.15 billion
- Posted on January 13, 2025
- By Business News Today
- 1 Views
GSK to buy US biotech firm IDRx for up to $1.15 billion
British drugmaker GSK agrees to acquire Boston-based biopharmaceutical firm IDRx for up to $1.15 billion, with an initial $1 billion payment. IDRx develops a treatment for gastrointestinal stromal tumours, contributing to GSK's expanding portfolio in gastrointestinal cancers amid its vaccine business challenges.
